Quick Answer
Whitehawk Therapeutics, Inc. reported Shares Outstanding of 47.15 million shares for fiscal year 2025.
Whitehawk Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 47.15M | +91.0% |
| 2024 | 24.68M | +0.5% |
| 2023 | 24.55M | +0.5% |
| 2022 | 24.44M | +16.9% |
| 2021 | 20.89M | +735.8% |
| 2021 | 2.50M | -1.7% |
| 2020 | 2.54M | -93.7% |
| 2019 | 40.59M | +0.0% |
| 2018 | 40.59M | +49.9% |
| 2017 | 27.07M | +2081.4% |
| 2016 | 1.24M | -75.2% |
| 2015 | 5.00M | +0.0% |
| 2014 | 5.00M | +0.0% |
| 2013 | 5.00M | +0.0% |
| 2012 | 5.00M | +0.0% |
| 2011 | 5.00M | +0.0% |
| 2010 | 5.00M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 47.13M | +91.5% | +0.0% |
| June 30, 2025 | 47.13M | +91.5% | +0.7% |
| March 31, 2025 | 46.78M | +90.5% | +89.6% |
| December 31, 2024 | 24.68M | +0.5% | +0.3% |
| September 30, 2024 | 24.61M | +0.4% | +0.0% |
| June 30, 2024 | 24.61M | +0.4% | +0.2% |
| March 31, 2024 | 24.55M | +0.5% | +0.0% |
| December 31, 2023 | 24.55M | +0.5% | +0.1% |
- Whitehawk Therapeutics, Inc. showed an increase of +91.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Whitehawk Therapeutics, Inc.’s shares outstanding has grown by 842.9% (from 5.00 million shares to 47.15 million shares).
- The most recent figure is from Whitehawk Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: